Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass

NCT01002859 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped difficulties to include patients

Conditions

Coronary Artery Bypass Surgery
Cardiopulmonary Bypass

Interventions

DRUG: Sandimmum
DRUG: Placebo

Sponsor

University Hospital, Grenoble